• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中18号染色体上候选抑癌基因的评估。

Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.

作者信息

Thiagalingam S, Lengauer C, Leach F S, Schutte M, Hahn S A, Overhauser J, Willson J K, Markowitz S, Hamilton S R, Kern S E, Kinzler K W, Vogelstein B

机构信息

Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.

出版信息

Nat Genet. 1996 Jul;13(3):343-6. doi: 10.1038/ng0796-343.

DOI:10.1038/ng0796-343
PMID:8673134
Abstract

Chromosome deletions are the most common genetic events observed in cancer. These deletions are generally thought to reflect the existence of a tumour suppressor gene within the lost region. However, when the lost region does not precisely coincide with a hereditary cancer locus, identification of the putative tumour suppressor gene (target of the deletion) can be problematic. For example, previous studies have demonstrated that chromosome 18q is lost in over 60% of colorectal as well as in other cancers, but the lost region could not be precisely determined. Here we present a rigorous strategy for mapping and evaluating allelic deletions in sporadic tumours, and apply it to the evaluation of chromosome 18 in colorectal cancers. Using this approach, we define a minimally lost region (MLR) on chromosome 18q21, which contains at least two candidate tumour suppressor genes, DPC4 and DCC. The analysis further suggested genetic heterogeneity, with DPC4 the deletion target in up to a third of the cases and DCC or a neighbouring gene the target in the remaining tumours.

摘要

染色体缺失是癌症中最常见的基因事件。这些缺失通常被认为反映了缺失区域内存在肿瘤抑制基因。然而,当缺失区域与遗传性癌症位点不完全一致时,鉴定假定的肿瘤抑制基因(缺失的靶点)可能会有问题。例如,先前的研究表明,超过60%的结直肠癌以及其他癌症中存在18号染色体q臂缺失,但无法精确确定缺失区域。在此,我们提出了一种用于绘制和评估散发性肿瘤中等位基因缺失的严谨策略,并将其应用于评估结直肠癌中的18号染色体。使用这种方法,我们在18号染色体q21上定义了一个最小缺失区域(MLR),该区域至少包含两个候选肿瘤抑制基因DPC4和DCC。分析进一步表明存在基因异质性,在多达三分之一的病例中,DPC4是缺失靶点,而在其余肿瘤中,DCC或其邻近基因是靶点。

相似文献

1
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.结直肠癌中18号染色体上候选抑癌基因的评估。
Nat Genet. 1996 Jul;13(3):343-6. doi: 10.1038/ng0796-343.
2
Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.在一部分胰腺癌和胆管癌中,纯合缺失会使DCC失活,但不会使MADH4/DPC4/SMAD4失活。
Genes Chromosomes Cancer. 2000 Apr;27(4):353-7.
3
Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.头颈部癌中18号染色体长臂存在多个不连续的缺失区域。
Clin Cancer Res. 1998 Mar;4(3):539-44.
4
Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.神经母细胞瘤中DCC、DPC4和MADR2/JV18-1基因的表达及突变分析
Cancer Res. 1997 Sep 1;57(17):3772-8.
5
No SMAD4 hypermethylation in colorectal cancer.结直肠癌中无SMAD4高甲基化现象。
Br J Cancer. 2000 Oct;83(8):1015-9. doi: 10.1054/bjoc.2000.1387.
6
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.前列腺癌和结直肠癌中DPC4(Smad4)的比较突变分析。
Oncogene. 1997 Aug 28;15(9):1111-4. doi: 10.1038/sj.onc.1201232.
7
Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.克罗地亚患者散发性结肠腺癌中DPC4肿瘤抑制基因的状态:一种新型体细胞突变的鉴定。
Mutat Res. 2004 Apr 14;548(1-2):61-73. doi: 10.1016/j.mrfmmm.2003.12.018.
8
DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.人类结直肠癌和胰腺癌转移中的DCC和SMAD4改变。
Oncogene. 2000 Jan 27;19(4):546-55. doi: 10.1038/sj.onc.1203353.
9
Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.浆液性卵巢癌的等位基因分析显示,在18q22 - q23区域存在两个假定的肿瘤抑制基因座,位于SMAD4、SMAD2和DCC远端。
Am J Pathol. 2001 Jul;159(1):35-42. doi: 10.1016/S0002-9440(10)61670-7.
10
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.结直肠癌中的SMAD4突变可能发生在染色体不稳定之前,但在微卫星不稳定途径分歧之后。
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9719-23. doi: 10.1073/pnas.171321498. Epub 2001 Jul 31.

引用本文的文献

1
The role of apoptosis and its potential as a therapeutic target in inflammatory bowel disease associated with colorectal cancer.细胞凋亡在与结直肠癌相关的炎症性肠病中的作用及其作为治疗靶点的潜力。
Am J Transl Res. 2025 Jul 25;17(7):5718-5745. doi: 10.62347/NCFF5626. eCollection 2025.
2
Targeting the KRAS Oncogene for Patients with Metastatic Colorectal Cancer.针对转移性结直肠癌患者的KRAS癌基因
Cancers (Basel). 2025 Apr 30;17(9):1512. doi: 10.3390/cancers17091512.
3
Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer.
Smad4缺失可识别出在胃癌中对免疫疗法和抗HER-2治疗具有抗性的侵袭性亚型。
Br J Cancer. 2025 Apr 25. doi: 10.1038/s41416-025-03002-8.
4
Cytogenetic signatures favoring metastatic organotropism in colorectal cancer.支持结直肠癌转移器官趋向性的细胞遗传学特征
Nat Commun. 2025 Apr 5;16(1):3261. doi: 10.1038/s41467-025-58413-1.
5
Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective.多蛋白生物标志物与结直肠癌的不同治疗策略:一项全面的前瞻性研究
Curr Med Chem. 2024;31(22):3286-3326. doi: 10.2174/0929867330666230505165031.
6
KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres.KaryoCreate:一种基于 CRISPR 的技术,通过靶向人类着丝粒研究染色体特异性非整倍性。
Cell. 2023 Apr 27;186(9):1985-2001.e19. doi: 10.1016/j.cell.2023.03.029. Epub 2023 Apr 18.
7
Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies.拷贝数变异作为液体活检中结直肠肿瘤进展的决定因素。
Int J Mol Sci. 2023 Jan 16;24(2):1738. doi: 10.3390/ijms24021738.
8
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.胰腺肿瘤发生:前体、遗传风险因素和筛查。
Curr Oncol. 2022 Nov 15;29(11):8693-8719. doi: 10.3390/curroncol29110686.
9
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.锯齿状结直肠病变:从组织学模式到分子发病机制的最新综述。
Int J Mol Sci. 2022 Apr 18;23(8):4461. doi: 10.3390/ijms23084461.
10
A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer.SMAD4 调节的基因谱可预测 II 期和 III 期结直肠癌的无病生存。
Cancer Rep (Hoboken). 2022 Jan;5(1):e1423. doi: 10.1002/cnr2.1423. Epub 2021 Jun 10.